These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 194650)

  • 1. Evolution of poliovirus since introduction of attenuated vaccine.
    Cossart YE
    Br Med J; 1977 Jun; 1(6077):1621-3. PubMed ID: 194650
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Neurologic complications associated with oral poliovirus vaccine and genomic variability of the vaccine strains after multiplication in humans.
    Friedrich F
    Acta Virol; 1998 Jun; 42(3):187-94. PubMed ID: 9842449
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Markers of poliovirus strains isolated from cases temporally associated with the use of live poliovirus vaccine: report on a W.H.O. collaborative study.
    J Biol Stand; 1981; 9(2):163-84. PubMed ID: 6165725
    [No Abstract]   [Full Text] [Related]  

  • 4. [Prevention of poliomyelitis: live or killed vaccine? Remarks apropos of 2 cases of poliomyelitis].
    Bergouignan FX; Saintarailles J; Roux D; Guillon J; Bonnici JF; Fleury H; Henry P
    Presse Med; 1984 Oct; 13(37):2241-3. PubMed ID: 6095246
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evolution of poliovirus since introduction of attenuated vaccine.
    Wyatt HV
    Br Med J; 1977 Aug; 2(6085):518. PubMed ID: 890381
    [No Abstract]   [Full Text] [Related]  

  • 6. Rational design of genetically stable, live-attenuated poliovirus vaccines of all three serotypes: relevance to poliomyelitis eradication.
    Macadam AJ; Ferguson G; Stone DM; Meredith J; Knowlson S; Auda G; Almond JW; Minor PD
    J Virol; 2006 Sep; 80(17):8653-63. PubMed ID: 16912313
    [TBL] [Abstract][Full Text] [Related]  

  • 7. An Introduction to Poliovirus: Pathogenesis, Vaccination, and the Endgame for Global Eradication.
    Minor PD
    Methods Mol Biol; 2016; 1387():1-10. PubMed ID: 26983727
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Rapid and accurate identification of poliovirus strains used for vaccine production.
    Nijst OE; Mouthaan JJ; Mekkes DR; Jusic E; van der Avoort HG; Metz B
    J Virol Methods; 2013 Apr; 189(1):189-95. PubMed ID: 23434540
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Update on Vaccine-Derived Polioviruses - Worldwide, January 2016-June 2017.
    Jorba J; Diop OM; Iber J; Henderson E; Sutter RW; Wassilak SGF; Burns CC
    MMWR Morb Mortal Wkly Rep; 2017 Nov; 66(43):1185-1191. PubMed ID: 29095803
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Letter: Poliomyelitis after contact with recently vaccinated infant.
    Wilson J; Robinson R
    Br Med J; 1974 Apr; 2(5909):53. PubMed ID: 4362453
    [No Abstract]   [Full Text] [Related]  

  • 11. Intratypic differentiation of poliovirus strains of type I from pre- and post-vaccination groups.
    Sevani HK; Gharpure PV
    Indian J Med Res; 1969 Sep; 57(9):1591-606. PubMed ID: 4313048
    [No Abstract]   [Full Text] [Related]  

  • 12. [Genetic markers of local poliovirus strains isolated during 1966-1969].
    Nikolova M; Tsilka E; Rangelova S; Giurova S
    Izv Mikrobiol Inst (Sofiia); 1971; 22():113-8. PubMed ID: 4340615
    [No Abstract]   [Full Text] [Related]  

  • 13. Random selection: a model for poliovirus infection of the central nervous system.
    Georgescu MM; Balanant J; Ozden S; Crainic R
    J Gen Virol; 1997 Aug; 78 ( Pt 8)():1819-28. PubMed ID: 9266975
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cessation of use of trivalent oral polio vaccine and introduction of inactivated poliovirus vaccine worldwide, 2016.
    Wkly Epidemiol Rec; 2016 Sep; 91(36-37):421-7. PubMed ID: 27623614
    [No Abstract]   [Full Text] [Related]  

  • 15. Decision analysis in planning for a polio outbreak in the United States.
    Jenkins PC; Modlin JF
    Pediatrics; 2006 Aug; 118(2):611-8. PubMed ID: 16882814
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Persistence of oral polio vaccine virus after its removal from the immunisation schedule in New Zealand.
    Huang QS; Greening G; Baker MG; Grimwood K; Hewitt J; Hulston D; van Duin L; Fitzsimons A; Garrett N; Graham D; Lennon D; Shimizu H; Miyamura T; Pallansch MA
    Lancet; 2005 Jul 30-Aug 5; 366(9483):394-6. PubMed ID: 16054940
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Childhood immunizations: position on the enhanced inactivated poliovirus vaccine and live attenuated oral poliovirus vaccine dilemma.
    Willis E; Sherrod JL
    J Natl Med Assoc; 1997 Dec; 89(12):785-9. PubMed ID: 9433057
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Development and introduction of inactivated poliovirus vaccines derived from Sabin strains in Japan.
    Shimizu H
    Vaccine; 2016 Apr; 34(16):1975-85. PubMed ID: 25448090
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Study of the biological properties of vaccinal strains of type 3 poliomyelitis virus isolated from children in Sverdlovsk].
    Shchekochikhina EA; Dodonova NN; Dzagurov SG; Omel'chenko TN; Tsetlin EM
    Vopr Virusol; 1973; 18(4):484-9. PubMed ID: 4362265
    [No Abstract]   [Full Text] [Related]  

  • 20. Risks associated with the use of live-attenuated vaccine poliovirus strains and the strategies for control and eradication of paralytic poliomyelitis.
    Pliaka V; Kyriakopoulou Z; Markoulatos P
    Expert Rev Vaccines; 2012 May; 11(5):609-28. PubMed ID: 22827246
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.